Logo image of EQUI.MI

EQUITA GROUP SPA (EQUI.MI) Stock Fundamental Analysis

Europe - BIT:EQUI - IT0005312027 - Common Stock

5.35 EUR
-0.03 (-0.56%)
Last: 9/17/2025, 12:29:36 PM
Fundamental Rating

5

Overall EQUI gets a fundamental rating of 5 out of 10. We evaluated EQUI against 112 industry peers in the Capital Markets industry. While EQUI is still in line with the averages on profitability rating, there are concerns on its financial health. EQUI has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

EQUI had positive earnings in the past year.
EQUI had a negative operating cash flow in the past year.
In the past 5 years EQUI has always been profitable.
The reported operating cash flow has been mixed in the past 5 years: EQUI reported negative operating cash flow in multiple years.
EQUI.MI Yearly Net Income VS EBIT VS OCF VS FCFEQUI.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

1.2 Ratios

The Return On Assets of EQUI (5.57%) is better than 75.89% of its industry peers.
The Return On Equity of EQUI (17.97%) is better than 79.46% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.24%, EQUI is in the better half of the industry, outperforming 75.89% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for EQUI is below the industry average of 8.46%.
The 3 year average ROIC (4.99%) for EQUI is below the current ROIC(6.24%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.57%
ROE 17.97%
ROIC 6.24%
ROA(3y)4.06%
ROA(5y)4.66%
ROE(3y)14.41%
ROE(5y)15.84%
ROIC(3y)4.99%
ROIC(5y)5.37%
EQUI.MI Yearly ROA, ROE, ROICEQUI.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 15.58%, EQUI is in line with its industry, outperforming 59.82% of the companies in the same industry.
EQUI's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 22.08%, EQUI is doing good in the industry, outperforming 66.07% of the companies in the same industry.
EQUI's Operating Margin has been stable in the last couple of years.
EQUI's Gross Margin of 91.44% is amongst the best of the industry. EQUI outperforms 90.18% of its industry peers.
EQUI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 22.08%
PM (TTM) 15.58%
GM 91.44%
OM growth 3Y-7.89%
OM growth 5Y1.01%
PM growth 3Y-9.76%
PM growth 5Y1.87%
GM growth 3Y-0.4%
GM growth 5Y0.03%
EQUI.MI Yearly Profit, Operating, Gross MarginsEQUI.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, EQUI has less shares outstanding
The number of shares outstanding for EQUI has been increased compared to 5 years ago.
The debt/assets ratio for EQUI has been reduced compared to a year ago.
EQUI.MI Yearly Shares OutstandingEQUI.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
EQUI.MI Yearly Total Debt VS Total AssetsEQUI.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of 1.76, we must say that EQUI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of EQUI (1.76) is better than 61.61% of its industry peers.
EQUI has a Debt/Equity ratio of 1.56. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.56, EQUI perfoms like the industry average, outperforming 46.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.56
Debt/FCF N/A
Altman-Z 1.76
ROIC/WACCN/A
WACCN/A
EQUI.MI Yearly LT Debt VS Equity VS FCFEQUI.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.99 indicates that EQUI should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.99, EQUI is doing good in the industry, outperforming 76.79% of the companies in the same industry.
EQUI has a Quick Ratio of 1.99. This is a normal value and indicates that EQUI is financially healthy and should not expect problems in meeting its short term obligations.
EQUI's Quick ratio of 1.99 is fine compared to the rest of the industry. EQUI outperforms 78.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 1.99
EQUI.MI Yearly Current Assets VS Current LiabilitesEQUI.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for EQUI have decreased by -8.58% in the last year.
The Earnings Per Share has been growing slightly by 5.00% on average over the past years.
The Revenue has decreased by -3.95% in the past year.
The Revenue has been growing slightly by 6.13% on average over the past years.
EPS 1Y (TTM)-8.58%
EPS 3Y-17.19%
EPS 5Y5%
EPS Q2Q%41.07%
Revenue 1Y (TTM)-3.95%
Revenue growth 3Y-3.87%
Revenue growth 5Y6.13%
Sales Q2Q%32.94%

3.2 Future

Based on estimates for the next years, EQUI will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.52% on average per year.
EQUI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.66% yearly.
EPS Next Y25.81%
EPS Next 2Y13.24%
EPS Next 3Y11.52%
EPS Next 5YN/A
Revenue Next Year13.87%
Revenue Next 2Y9.65%
Revenue Next 3Y7.66%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EQUI.MI Yearly Revenue VS EstimatesEQUI.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
EQUI.MI Yearly EPS VS EstimatesEQUI.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 13.37, the valuation of EQUI can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of EQUI indicates a somewhat cheap valuation: EQUI is cheaper than 73.21% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.20. EQUI is valued rather cheaply when compared to this.
EQUI is valuated correctly with a Price/Forward Earnings ratio of 13.20.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EQUI indicates a somewhat cheap valuation: EQUI is cheaper than 79.46% of the companies listed in the same industry.
EQUI's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.71.
Industry RankSector Rank
PE 13.37
Fwd PE 13.2
EQUI.MI Price Earnings VS Forward Price EarningsEQUI.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EQUI.MI Per share dataEQUI.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5 2

4.3 Compensation for Growth

EQUI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of EQUI may justify a higher PE ratio.
PEG (NY)0.52
PEG (5Y)2.67
EPS Next 2Y13.24%
EPS Next 3Y11.52%

More info and screens

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.81%, EQUI is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.14, EQUI pays a better dividend. On top of this EQUI pays more dividend than 93.75% of the companies listed in the same industry.
EQUI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 6.81%

5.2 History

The dividend of EQUI is nicely growing with an annual growth rate of 14.37%!
Dividend Growth(5Y)14.37%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

109.70% of the earnings are spent on dividend by EQUI. This is not a sustainable payout ratio.
The dividend of EQUI is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP109.7%
EPS Next 2Y13.24%
EPS Next 3Y11.52%
EQUI.MI Yearly Income VS Free CF VS DividendEQUI.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M
EQUI.MI Dividend Payout.EQUI.MI Dividend Payout, showing the Payout Ratio.EQUI.MI Dividend Payout.PayoutRetained Earnings

More info and screens

EQUITA GROUP SPA

BIT:EQUI (9/17/2025, 12:29:36 PM)

5.35

-0.03 (-0.56%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-12 2024-11-12
Earnings (Next)N/A N/A
Inst Owners7.56%
Inst Owner ChangeN/A
Ins Owners8.13%
Ins Owner ChangeN/A
Market Cap281.78M
Analysts44
Price Target5.25 (-1.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.81%
Yearly Dividend0.43
Dividend Growth(5Y)14.37%
DP109.7%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3%
PT rev (3m)3%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.04%
EPS NY rev (3m)1.04%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.03%
Revenue NY rev (3m)2.63%
Valuation
Industry RankSector Rank
PE 13.37
Fwd PE 13.2
P/S 2.33
P/FCF N/A
P/OCF N/A
P/B 2.68
P/tB 3.6
EV/EBITDA N/A
EPS(TTM)0.4
EY7.48%
EPS(NY)0.41
Fwd EY7.58%
FCF(TTM)-0.62
FCFYN/A
OCF(TTM)-0.6
OCFYN/A
SpS2.3
BVpS1.99
TBVpS1.48
PEG (NY)0.52
PEG (5Y)2.67
Profitability
Industry RankSector Rank
ROA 5.57%
ROE 17.97%
ROCE 8.98%
ROIC 6.24%
ROICexc 8.41%
ROICexgc 10.72%
OM 22.08%
PM (TTM) 15.58%
GM 91.44%
FCFM N/A
ROA(3y)4.06%
ROA(5y)4.66%
ROE(3y)14.41%
ROE(5y)15.84%
ROIC(3y)4.99%
ROIC(5y)5.37%
ROICexc(3y)7.47%
ROICexc(5y)8.18%
ROICexgc(3y)9.56%
ROICexgc(5y)10.17%
ROCE(3y)7.3%
ROCE(5y)9.68%
ROICexcg growth 3Y-21.55%
ROICexcg growth 5Y17.77%
ROICexc growth 3Y-22.51%
ROICexc growth 5Y13.48%
OM growth 3Y-7.89%
OM growth 5Y1.01%
PM growth 3Y-9.76%
PM growth 5Y1.87%
GM growth 3Y-0.4%
GM growth 5Y0.03%
F-Score3
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 1.56
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.84%
Interest Coverage 2.24
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.99
Quick Ratio 1.99
Altman-Z 1.76
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)1.74%
Cap/Sales(5y)4.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.58%
EPS 3Y-17.19%
EPS 5Y5%
EPS Q2Q%41.07%
EPS Next Y25.81%
EPS Next 2Y13.24%
EPS Next 3Y11.52%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.95%
Revenue growth 3Y-3.87%
Revenue growth 5Y6.13%
Sales Q2Q%32.94%
Revenue Next Year13.87%
Revenue Next 2Y9.65%
Revenue Next 3Y7.66%
Revenue Next 5YN/A
EBIT growth 1Y-17.33%
EBIT growth 3Y-11.45%
EBIT growth 5Y7.2%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-224.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-206.6%
OCF growth 3YN/A
OCF growth 5YN/A